Background: Numerous investigations demonstrate a novel role of thyroid hormone as a modulator of signal transduction. Protein kinase C (PKC) is critical to the mechanism by which thyroid hormones potentiate both the antiviral and immunomodulatory actions of IFNγ in different cells and regulate the exchange of signalling phospholipids in hepatocytes. Because nothing is known about accumulation of PKC modulator -diacylglycerol in cells treated with T 4 , we examined the nongenomic effect of thyroid hormones on DAG formation and phospholipase activation in liver cells.
Background
Thyroid hormone exerts a broad range of effects on development, growth and metabolism. The actions of thyroid hormone are primarily the result of their interaction with nuclear receptors that bind to regulatory regions of genes (thyroid hormone -response elements) and modi-fy their expression. Nuclear mechanisms of thyroid hormone action have been extensively described [reviewed in 1, 2] , but an increasing number of nogenomic effects of the hormone at the cellular level have been recognized in the past 10 years [reviewed in 3] . Nongenomic actions of thyroid hormone are by definition independent on nuclear receptors for the hormone and have been described at the plasma membrane, various organelles, the cytoskeleton, and in cytoplasm. The actions include alterations in transport of Ca
+2
, Na + and glucose; changes in activities of several kinases, including protein kinase C (PKC), cAMP -dependent protein kinase and mitogenactivated protein kinase. Iodothyronines also can regulate nongenomically through a PKC activation of neutral lipids, phospholipids [4] and phosphatidylinositol 4,5-bisphosphate (PtdIns (4,5)P 2 ) [5] synthesis in rat hepatocytes. It has been determined that in HeLa cells potentiation by thyroxine (T 4 ) interferon -gamma -induced antiviral state requires PKC and phospholipase C (PLC) activities [6] . Direct evidence of the nongenomic PKC activation by thyroid hormones has been found in rabbit erythrocytes [7] . The regulation of PKC is critical to the mechanism by which thyroid hormones rapidly induce phosphorylation and nuclear translocation of mitogenactivated protein kinase and subsequently potentiate both the antiviral and immunomodulatory actions of IFNγ in cultured cells [8] .
It is widely demonstrated on various cell types that interaction of Ca +2 -mobilizing hormones and transmitters with the cell surface receptors leads to the phospholipid breakdown under PLC or -D action and accumulation of inosite phosphates and diacylglycerol (DAG). The regulatory molecules generation is accompanied by intracellular free calcium concentration increase and, as a result, by PKC activation.
An addition of the physiological doses of thyroid hormones to the cell suspension rapidly increases the intracellular calcium concentration in rat hepatocytes and single rat heart cell [9, 10] . On the other hand, there is no information about accumulation of other PKC modulator -DAG in the cells on T 4 administration. However, such genomic independent effect on the different types of cells has been determined for steroid hormones [11] [12] [13] whose mechanism of action on target cells is known to be similar to that of the thyroid hormones.
In the present study, we have examined the nongenomic effect of thyroid hormones on DAG formation and PKC activation in liver cells. It was determined that L-T 4 rapidly induces the biphasic DAG accumulation in liver slices and isolated hepatocytes. The data obtained provide evidence that L-T 4 activates PLC and -D in sequential manner that leads to increasing DAG formation during sustained agonist stimulation. The L-T 4 -induced PLD -PA phosphohydrolase (PAP) pathway of DAG generation in rat hepatocytes is highly specific and PKC -dependent. 14 C]oleic acid labeled hepatocytes (B) were treated with 100 nM NaOH (control) or 10 nM L-T 4 for indicated times. Lipids were extracted, separated by TLC, and analyzed as described in "Materials and Methods". Basal lipid levels in control cells (Fig. 1B) did not change significantly over the experimental period and were (cpm/10 7 cells): PI -4721 ± 633, PI(4)P -4265 ± 264, PI(4,5)P2 -3605 ± 317, PC -7662 ± 344, DAG -6008 ± 106. Results represent the mean ± S.E. of four individual experiments. * P < 0.05 vs. control.
Results and Discussion
This study was carried out to examine DAG formation and degradation of phospholipids in rat liver cells treated with the thyroid hormones. It was demonstrated that L-T 4 induced a biphasic formation of DAG peaking at 15 sec and 1-2 min (Fig. 1A, B) . Early phase was abolished by neomycin sulfate, a specific inhibitor of phosphoinositide hydrolysis (Table 1) , and accompanied by PtdIns(4,5)P 2 level decrease (Fig. 1B) . It has also been shown that L-T 4 stimulates inositol 1,4,5-trisphosphate (Ins(l,4,5)P 3 ) formations in [3H]inositol pre-labeled hepatocytes. Basal and hormone-induced Ins(l,4,5)P 3 levels in liver cells were 840+25 and 1832+42 cpm/10 7 cells, respectively (time of treatment: 0.25 min, n = 6, P < 0.05).
Many cells produce DAG in a biphasic manner, involving an initial and usually transient rise in DAG that is correlated with phosphoinositide -specific PLC activation followed by a sustained increase in DAG derived from phosphatidylcholine (PC) hydrolysis [14] .It is shown in the present study that the second phase of DAG production in liver slices (Fig. 1A ) and isolated hepatocytes (Fig.  1B) coincided with hormone-stimulated PC content decrease. L-T 4 -induced DAG formation in hepatocytes was concentration-dependent and highly specific as D-T 4 failed to accumulate DAG ( Fig. 2A) . In rat hepatocytes, it has been reported that various regulatory factors such as phorbol esters, guanine nucleotide-binding proteins, hepatocyte growth factor, vasopressin and insulin caused PC-dependent PLD activation and DAG formation [15] [16] [17] [18] . PLD catalyzed hydrolytic cleavage of the terminal diester bound of phospholipids, resulting in the ]oleic acid labeled hepatocytes were pre-incubated for 15 min prior to NaOH (l00 nM) or LT 4 (l0 nM) addition or pre-incubated for 15 min with neomycin sulfate (1.5 mM) or propranolol (100 nM) prior to stimulation with L-T 4 (l0 nM).The data are mean ± S.E. of four separate experiments. * P < 0.05 vs. control. ]oleic acid labeled hepatocytes were pre-incubated for 15 min with H7 (50 µM) or NaOH (l00 nM) alone prior to stimulation with L-T 4 for 2 min. 1.5% ethanol was added 15 min before L-T 4 addition or together with H7 (50 µM) or NaOH (100 nM) for determination of Peth formation in the cells. The data are mean ± S.E. of four separate experiments. * P < 0.05 vs. control. direct formation of PA and the respective base. The PA produced can be converted to DAG by the action of PAP. A unique property of PLD, which provides a specific assay for this enzyme, is the transphosphatidylation reaction to generate the corresponding phosphatidylalcohol in the presence of primary alcohol.
In the present study, to determine the PLD activity, the formation of phosphatidylethanol (Peth) was measured in intact (Fig. 2B) and [ 14 C]oleic acid pre-labeled cells (Table 2 ) in the presence of 1.5% ethanol. L-T 4 stimulatory effect on Peth formation was specific and concentration-dependent (Fig. 2B) . To determine if PC could be the substrate for the PLD in L-T 4 -stimulated cells the effect of hormone on isolated plasma membranes has been investigated in the presence of [ 14 C-methyl]PC (Fig. 3) . It was found that L-T 4 rapidly stimulated [
14 C]PC degradation and free [ (Fig. 2B ). Early work [19] has shown that L-T 3 rapidly induced choline and PA accumulation in liver slices. To assess the possibility of PA conversion to DAG in hormone-stimulated liver cells we have used propranolol, which is known to block the conversion of PA to DAG by inhibiting PAP. 100 nM propranolol was added 15 min prior to the hormone to [ (Table 1) . Inhibitor of polyphosphoinositide-specific PLC, neomycin sulfate, nullified the first rise of DAG production and decreased the second one in hormone stimulated cells. In rat hepatocytes, commonly used PKC inhibitors, 1,(5-isoquinolinesulphonyl)2methylpiperasine dihydrochloride (H7), Ro31-8425 and calphostin C, inhibited HGF-, vasopressin-and insulin -induced PC-specific PLD, suggesting that PLD activity is regulated by PKC [16, 18] . (Table 2 ). Pre-incubation of liver cells with L-T 4 leads to translocation of PKC from cytosol to membrane fraction and its activation. D-T 4 had no effect on enzyme activity of the fractions investigated. The PKC activity in membranes isolated from control (100 nM NaOH-treated cells) and D-T 4 (10 nM)-treated hepatocytes was 1040 ± 111 and 865 ± 61 pmol/mg protein/min, respectively, and 1593 ± 167 and 937 ± 120 pmol/mg protein/min in cytosol of control and hormone-treated cells, respectively. However, the enzyme activity in L-T 4 -induced cells was 9498 ± 224 pmol/mg protein/min (for membrane; P control-L-T4 < 0,05, n = 4) and 633 ± 20 pmol/mg protein/min (for cytosol).
Figure 2 Dose-dependent action of thyroid hormone on DAG (A), choline and Peth (B) formation in hepatocytes.
[ 14 C]oleic acid pre-labeled cells were treated with 100 nM NaOH (control) or thyroid hormones for 2 min (A). The DAG level in control cells: 4707 ± 544 cpm/10 7 cells. To determine Peth formation in intact hepatocytes(B), 1.5% ethanol was added 15 min before hormone addition. Cells were treated with hormones for 2 min. Reaction was stopped by addition of ice-cold methanol to the culture dishes. Lipid extraction was performed as described in [17] . Peth was separated by silica gel plates in a solvent system of upper phase of ethyl acetate/2,2,4-trimethylpentane/acetic acid/water (13:2:3:10, v/v). The Peth area identified by co-migration with Peth standard was scraped off the plates and the radioactivity was determined by a liquid scintillation counter. The intensity of the lipid spots was estimated by densitometry using a LKB Ultroscan laser densitometer. Free choline content was determined in intact control and hormone-treated cells by the method described in [18] . Results are mean ± S.E. of five individual experiments. * P < 0.05 vs.control.
Conclusions
The investigations made indicate that in liver cells L-T 4 rapidly stimulates the hydrolysis of polyphosphoinositides by PLC with the resultant production of the second messengers inositol triphosphate as well as DAG and PKC activation. The major new finding of this study was that in hepatocytes L-T 4 stimulated PC cleavage by PLD. As in the other cells, operated by Ca 2+ -mobilizing receptors, PLD contributes to DAG formation in L-T 4 -stimulated hepatocytes. DAG formed by PA breakdown could further activate PKC in hormone-treated cells. Inhibitor of PLC-dependent phosphoinostide hydrolysis, neomycin sulfate, completely abolishes the first phase of DAG production and reduces the PLD-dependent DAG response to L-T 4 , indicating that PLD is activated during the PLC-dependent signaling in liver cells. These data indicate that L-T 4 activates a dual phospholipase pathway in a sequential and synchronized manner. PLC initiates the increase in Ins(l,4,5)P 3 and DAG formation and PKC mediates integration of PLD into the signaling response during the sustained phase of agonist stimulation. The effect of L-T 4 on PKC, PLD activation and DAG accumulation is highly specific and too rapid (from seconds to a few minutes) to be compatible with mRNA and protein synthesis. These results provide the first evidence concerning L-T 4 nongenomic stimulation of phospholipid hydrolysis by phospholipases and DAG accumulation in liver slices and isolated hepatocytes. silica gel from Woelm (Germany).Phosphatidylserine was isolated from ox brain; other lipid standards, histone (typeIII), H7, propranolol and neomycin were obtained from Sigma (USA). Other chemicals used were of chemically pure grade.
Materials and Methods

Materials
Cell Suspension Experiments
Hepatocytes were isolated from the adult 90-day-old male Wistar rats which had a free access to food and water and were kept at 24°C on a cycle of 12 h light/12 h darkness by the method described in [5] . Preparation of hepatocytes was started between 9:00 and 10:00 a.m. Cells (10 7 /ml) were labeled by incubation in Eagle medium containing 10% fetal calf serum, 100 units/liter streptomycin, 100 units/liter penicillin, 13 mg/ml gentamycin and 2.5 µCi/ml of [ 14 C]oleic acid for 3 h in 95% 02/5% CO 2 atmosphere at 37°C. Before hormones addition, cells were washed twice with a Krebs-Henseleit buffer pH 7.4, containing 2 mM CaCl 2 , 25 mM HEPES, 0.1% BSA, and then preincubated at 37°C for 1 h. After adding L-T 4 or D-T 4 or NaOH only to the cell suspension (3 × 10 6 cells/ml), the probes were incubated for different periods. Reactions were stopped with ice-cold mixture of chloroform and methanol (2:1, v/v). The PLD activity in response to T 4 was determined by measuring the formation of Peth as was previously described [20] . The free choline content in intact cells was analyzed by the method [21] .
Experiments with Liver Slices
The 1 mCi of [ 14 C]CH 3 COOH was intraperitoneally injected four times every 30 minutes for 2 hours to rats [21] . The liver was perfused with 0.9% NaCl, then removed and washed in Krebs-Henseleit buffer, pH 7.4, containing 2 mM CaCl 2 and 0.2% BSA. Slices of liver were preincubated in Krebs-Henseleit buffer for 10 minutes before hormones addition. Reaction was stopped with ice-cold mixture of chloroform and methanol (2:1, v/v). The lipids were extracted and analyzed as described below.
Isolation and Incubation of Liver Cell Plasma Membranes
Plasma membranes were prepared using differential centrifugation through various concentration of sucrose and characterized by their specific marker enzymes as described [22] . For PC hydrolysis, [ 14 C]lipids were extracted and analyzed as described below.
Extraction and Separation of Lipids
Lipids were extracted according to Folch et al [23] and phosphoinositides as described in [24] . The chloroform phase was collected and dried under N 2 at 37°C. The lipids were redissolved in chloroform/methanol (1:2, v/v) and applied on TLC plates. For isolation of DAG the solvent system: hexane/diethyl ether/acetic acid (80:20:2, v/v) was used; for PC separation -chloroform/methanol/ acetic acid/water (25:15:4:2, v/v) and for ItdIns(4,5)P 2 -chloroform/methanol/NH 4 OH (50:40:10, v/v). Appropriate standards were applied on each plate for quantification. The gel spots containing lipids were scraped and transferred to scintillation vials. Radioactivity was measured by scintillation counter. 
H]Inositol Labeling of Hepatocytes and Determination of Inositol Phosphates Release in Stimulated Cells
Freshly isolated hepatocytes were plated in Petri dishes (9 × 10 6 cells/dish) in Williams E medium containing 10% fetal calf serum, 20 units/I penicillin, 13 mg/ml gentamycin and 4 mg/ml dexametasone, 10 µCi myo-[ 3 H]inositol [25] . After 24-h incubation, the cells were washed three times with inositol-free Williams E medium, containing 0.1% BSA, then preincubated in the presence of 20 mM LiCl 2 for 15 min, and incubated for 0.25 min in the presence of 0.1 µM of L-T 4 . Reactions were performed at 37°C and stopped at the indicated time by removing the medium and washing three times with the same inositol-free medium. The samples preparation and inositol phosphates analysis were done as described previously [24] .
Protein kinase C Enzyme Assay
Activities of protein kinase C in the cytosol and in the crude membrane fraction of hormone-treated (10 nM for 5 min) and control (100 nM NaOH) hepatocytes were determined after partial purification of the enzyme by chromatography on DEAE-cellulose [26] . The activity of protein kinase C was determined by the transfer of 32 P from [γ-32 P]ATP into HI histone in the presence of phosphatidylserine and Ca 2+ (0.2 mM).This approach measures all the isoforms of PKC. The enzyme activity was expressed as pmoles of phosphate transferred from [γ-32 P]ATP into HI histone per minute. The protein content was determined by the method of Bradford [27] .
Abbreviations
T 4 -thyroxine, PKC -protein kinase C, PtdIns(4,5)P 2 -phosphatidylinositol 4,5-bisphosphate, PLC -phospholipase C, PLD -phospholipase D, DAG -diacylglycerol, PA -phosphatidic acid, PC -phosphatidylcholine, Ins(l,4,5)P 3 -inositol 1,4,5-trisphosphate, Peth -phosphatidylethanol.
